Every Form 4 that Calumet, Inc. (CLMT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLMT filings page.
Calumet, Inc. (CLMT) Chief Executive Officer Louis Todd Borgmann exercised 107,428 restricted stock units on September 25, 2026, acquiring 107,428 common shares. The units vested 100% on August 1, 2026. Upon delivery of common stock, he surrendered 46,901 shares to satisfy tax withholding liabilities.
Calumet, Inc. (CLMT) reported that Bruce A. Fleming, EVP - Montana Renewables, exercised 107,428 restricted stock units on September 25, 2026, acquiring 107,428 common shares. He surrendered 42,190 common shares to satisfy tax withholding liabilities upon delivery of the shares, in accordance with Rule 16b-3.
Calumet, Inc. (CLMT) SVP, General Counsel Gregory J. Morical reported converting 30,694 restricted stock units into 30,694 common shares on September 25, 2026. He surrendered 13,560 shares to satisfy tax-withholding liabilities upon delivery of the shares. The units had vested in full on August 1, 2026; no Rule 10b5-1 plan is reported.
Calumet, Inc. (CLMT) director Stephen P. Mawer reported converting 61,387 restricted stock units into 61,387 common shares on September 25, 2026. He elected to have 40% of vested units settled in the cash equivalent of a common share. He also reported a sale of 24,555 common shares at a reported price of $0.0000 per share.
Calumet, Inc. /DE (symbol: CLMT) is the issuer of record for a Form 4 filing submitted to the SEC.
Calumet, Inc. /DE (symbol: CLMT) is the issuer of record for a Form 4 filing submitted to the SEC.
Calumet, Inc. /DE (symbol: CLMT) is the issuer of record for a Form 4 filing submitted to the SEC.
Calumet, Inc. /DE (symbol: CLMT) is the issuer of record for a Form 4 filing submitted to the SEC.
Calumet, Inc. director John G. Boss reported compensation-related equity activity. On July 9, 2026, he exercised 7,067 Restricted Stock Units, each equivalent to one share of common stock, resulting in an equivalent number of common shares. In connection with this vesting, he surrendered 2,827 common shares to satisfy tax withholding liabilities, as permitted under Rule 16b-3. Following these transactions, he held 33,033 common shares directly.
Calumet, Inc. director Stephen P. Mawer reported compensation-related equity activity. On July 9, 2026, he exercised 13,780 Restricted Stock Units, each convertible into one share of common stock, following 100% vesting on June 2, 2026. In connection with the delivery of these shares, he surrendered 5,512 shares of common stock to satisfy tax withholding liabilities in accordance with Rule 16b-3, a non-market tax-withholding disposition. After these transactions, he held 311,578 shares of Calumet common stock directly.
Calumet, Inc. director Raymond Paul C reported compensation-related equity activity. On July 9, 2026, he exercised 7,067 Restricted Stock Units, each converting into one share of common stock, and received Calumet, Inc. common stock, par value $0.01 per share. To satisfy tax withholding liabilities upon delivery of the shares and in accordance with Rule 16b-3, he surrendered 2,827 shares back to the issuer. Following these transactions, he directly holds 28,973 shares of Calumet common stock.
Calumet, Inc. director Daniel J. Sajkowski reported compensation-related equity activity. On July 9, 2026, 7,067 Restricted Stock Units, each equal to one share of common stock, were converted into common shares following 100% vesting on June 2, 2026. To cover tax withholding liabilities, he surrendered 2,827 common shares under Rule 16b-3, a non-market disposition mechanism. After these transactions, he holds 81,958 common shares directly.
Calumet, Inc. director Amy M. Schumacher reported the exercise and conversion of 7,067 Restricted Stock Units into an equal number of shares of common stock, par value $0.01 per share, on July 9, 2026. Each Restricted Stock Unit was the economic equivalent of one share of common stock, and 100% of these units vested on June 2, 2026. Following the transaction, Schumacher directly holds 258,160 shares of Calumet, Inc. common stock. The filing does not report any open-market purchases or sales, only the derivative exercise and corresponding share issuance.
Calumet, Inc. director Julio M. Quintana exercised restricted stock units into common stock. On July 9, 2026, he converted 7,067 restricted stock units into 7,067 shares of common stock, par value $0.01 per share. Following the transaction, he held 7,067 common shares directly. The restricted stock units, each economically equivalent to one share of common stock, had 100% vested on June 2, 2026.
Calumet, Inc. director Karen G. Narwold reported the vesting and settlement of equity awards. On July 9, 2026, she exercised 7,067 Restricted Stock Units, each economically equivalent to one share of Calumet, Inc. common stock, into 7,067 shares of common stock. The footnotes state that 100% of these Restricted Stock Units vested on June 2, 2026, and following the transactions she holds 7,067 common shares directly, with no remaining units from this grant.
Calumet, Inc. director Karen A. Twitchell reported the vesting and settlement of equity awards. On July 9, 2026, she exercised 7,067 Restricted Stock Units, each equivalent to one share of common stock, into 7,067 shares of common stock. Following the transaction, she directly holds 13,389 shares of Calumet, Inc. common stock, while the reported Restricted Stock Unit balance is reduced to zero. The footnotes state that 100% of these Restricted Stock Units vested on June 2, 2026.
Calumet, Inc. director Daniel J. Sajkowski reported an open-market sale of 4,240 shares of common stock at a weighted average price of $36.16 per share. After this transaction, he directly holds 77,718 shares, so the sale represents a relatively small portion of his position.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025, when the stock closed at $19.08 per share. The shares were sold in multiple trades at prices ranging from $35.72 to $36.33 per share.
Heritage Group, a 10% owner of Calumet, Inc., reported a charitable gift of 540,000 shares of Common Stock. The shares were transferred as a bona fide gift at a reported price of $0.00 per share to The J.E. Fehsenfeld Family Foundation, Inc., a tax-qualified private foundation.
Following the gift, Heritage Group reports direct ownership of 12,440,211 Calumet shares. It also reports indirect beneficial ownership of 1,200,000 shares held by The Heritage Group Investment Company, LLC and 882,974 shares held by Lumet Investments, Inc., while disclaiming beneficial ownership of those indirect holdings except to the extent of any pecuniary interest.
SANDERS BRADFORD TIMOTHY reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Bradford Timothy Sanders received a grant of 3,461 Restricted Stock Units (RSUs) that are the economic equivalent of 3,461 shares of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.
Raymond Paul C reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Raymond Paul C received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock.
The Restricted Stock Units vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting, and will be settled in stock upon vesting. After this award, he holds 3,461 units directly.
Twitchell Karen A. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Karen A. Twitchell received a grant of 3,461 restricted stock units (RSUs). Each RSU is the economic equivalent of one share of Calumet common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting and will be settled upon vesting.
After this compensation-related award, Twitchell holds 3,461 RSUs directly. This is a routine equity grant to a director, not an open-market share purchase or sale.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss received a grant of 3,461 Restricted Stock Units (RSUs). Each RSU represents the economic equivalent of one share of Calumet common stock. Following this award, he holds 3,461 RSUs directly.
The RSUs vest upon the earlier of June 2, 2027 or the date Calumet holds its 2027 Annual Meeting, and will be settled in shares when they vest. This is a compensation-related equity award rather than an open‑market stock purchase or sale.
Quintana Julio M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Julio M. Quintana reported an equity compensation grant of 3,461 Restricted Stock Units (RSUs), each equal to one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting and are settled in shares upon vesting. Following this grant, Quintana holds 3,461 RSUs directly, with no open-market buy or sell activity disclosed.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer received a grant of 6,092 Restricted Stock Units (RSUs). Each RSU represents one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting, and will be settled in shares at vesting. Following this grant, Mawer holds 6,092 RSUs directly.
Schumacher Amy M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Amy M. Schumacher received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock, par value $0.01 per share.
The RSUs vest on the earlier of June 2, 2027 or the date of Calumet’s 2027 Annual Meeting, and will be settled upon vesting. Following this compensation award, Schumacher holds 3,461 RSUs directly.
Sajkowski Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Daniel J. Sajkowski received a grant of 3,461 Restricted Stock Units, each economically equivalent to one share of common stock. This is a stock-based compensation award rather than an open-market trade. Following the grant, he holds 3,461 units directly.
The Restricted Stock Units vest on the earlier of June 2, 2027 or the date of Calumet, Inc.’s 2027 Annual Meeting, and will be settled in shares upon vesting. This aligns director compensation with future company performance over the next several years.
NARWOLD KAREN G reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Karen G. Narwold received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock. These RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer reported receiving two grants of restricted stock units on May 28, 2026. He was awarded 322 restricted stock units and a separate grant of 968 units, each economically equivalent to one share of common stock.
The 322 restricted stock units are 100% vested and will be settled in shares upon the earlier of a date he specifies or his termination date. The 968 restricted stock units will be settled under the Deferred Compensation Plan on the earlier of a specified date or termination, with 25% vesting each July 1 beginning in 2027.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss reported compensation-related equity grants. On 2026-05-28, he received two awards totaling 281 Restricted Stock Units, each economically equivalent to one share of Calumet common stock.
One 70-unit award is 100% vested and will be settled upon the earlier of a date he specifies or his termination date. The 211-unit award is granted under the Deferred Compensation Plan, with 25% of the units vesting on July 1 each year beginning on July 1, 2027, and settlement also occurring upon the earlier of his specified date or termination.
Raymond Paul C reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Raymond Paul C reported compensation-related equity grants. On May 28, 2026, he received two awards of Calumet Restricted Stock Units (RSUs) that are each economically equivalent to common shares of Calumet, Inc. common stock.
The first grant covers 234 RSUs, is 100% vested, and results in total holdings of 234 RSUs from that award. The second grant covers 704 RSUs, with 25% vesting each July 1 beginning on July 1, 2027, and total holdings of 704 RSUs from that award.
Both RSU awards have a grant price of $0.00 per unit and will settle in stock upon the earlier of a date specified by the reporting person or his termination date under the company’s deferred compensation plan.
Schumacher Amy M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Amy M. Schumacher reported compensation-related equity grants in the form of restricted stock units. On May 28, 2026, she received two awards covering 214 and 644 restricted stock units, each economically equivalent to one share of Calumet common stock.
The 214-unit award is fully vested and will be settled in shares on the earlier of a date she specifies or her termination. The 644-unit award is under the company’s Deferred Compensation Plan, with 25% of those units vesting on July 1 of each year beginning in 2027, and settling on the earlier of a specified date or termination.
Heritage Group, a 10% owner of Calumet, Inc., reported a cashless exercise of warrants to purchase 1,020,000 shares of common stock at $20.00 per share. The issuer withheld 626,998 shares to pay the exercise price and issued the remaining 393,002 shares of common stock to the reporting person.
After these transactions, the filing shows 13,607,209 shares of common stock held directly, plus 1,200,000 shares owned by The Heritage Group Investment Company, LLC and 882,974 shares held by Calumet, Incorporated, both attributed as indirect holdings with beneficial ownership disclaimed except for any pecuniary interest.
Calumet, Inc. director Daniel J. Sajkowski sold 3,310 shares of common stock in an open-market transaction. The sale occurred on April 1, 2026 at a weighted average price of $34.46 per share, with individual trade prices ranging from $33.75 to $35.84.
The transaction was effected under a Rule 10b5-1 trading plan adopted on November 18, 2025, when Calumet, Inc. stock closed at $19.08 per share. After this sale, Sajkowski directly holds 81,958 shares of Calumet, Inc. common stock.
Morical Gregory J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. (CLMT) senior vice president and general counsel Gregory J. Morical received two grants of restricted stock units. One award covers 1,002 Restricted Stock Units that are 100% vested and economically equal to 1,002 shares of common stock, to be settled on a date he specifies or on his termination.
A second award covers 334 Restricted Stock Units, each equal to one share of common stock, to be settled under the Deferred Compensation Plan on the earlier of a specified date or his termination date. For this award, 25% of the units vest on July 1 of each year beginning on July 1, 2027.
Fleming Bruce A reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. executive Bruce A. Fleming reported awards of restricted stock units tied to the company’s common stock. On March 31, 2026, he received 13,047 restricted stock units that are 100% vested and will be settled on the earlier of a date he specifies or his termination date.
On the same date, he also received 4,349 restricted stock units under a Deferred Compensation Plan that will be settled on the earlier of a specified date or his termination. For this award, 25% of the units vest on July 1 of each year beginning on July 1, 2027. Each unit is the economic equivalent of one share of Calumet, Inc. common stock, so these are compensation-related equity grants rather than open-market share purchases or sales.
Borgmann Louis Todd reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. chief executive officer Louis Todd Borgmann reported awards of restricted stock units that function as stock-based compensation, not open-market trades. He received 7,173 restricted stock units and 2,391 restricted stock units, each economically equivalent to one share of Calumet, Inc. common stock.
The 7,173-unit grant is already 100% vested and will be settled in shares upon the earlier of a date he specifies or his termination date. The 2,391-unit grant will vest in 25% increments each July 1 beginning in 2027 and will be settled on the earlier of a specified date or his termination under the company’s Deferred Compensation Plan.
Krutz John Robert reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc.’s Chief Accounting Officer John Robert Krutz reported two compensation-related equity awards in the form of restricted stock units. He received 931 Restricted Stock Units, each equal to one share of common stock, which are 100% vested and will be settled on a date he specifies or upon his termination.
He also received 310 Restricted Stock Units that will be settled under the company’s Deferred Compensation Plan on the earlier of a specified date or his termination, with 25% of these units vesting on July 1 of each year beginning on July 1, 2027.
Calumet, Inc. EVP – Specialties Scott Obermeier exercised 24,090 restricted stock units into common shares on March 9, 2026. Each unit was economically equivalent to one share of common stock. To satisfy tax withholding liabilities, he surrendered 10,584 common shares to the company rather than selling them in the market. After these compensation-related transactions, he directly owned 237,656 shares of Calumet common stock.
Calumet, Inc. (CLMT) senior vice president and general counsel Gregory J. Morical exercised vested restricted stock units and settled related taxes in shares. On March 9, 2026, he converted 15,348 Restricted Stock Units into 15,348 shares of common stock at an exercise price of $0.00 per share.
Footnotes state that each Restricted Stock Unit equaled one share of common stock and that 100% of the units vested on February 21, 2026. To cover tax withholding obligations under Rule 16b-3, he surrendered 6,952 shares of common stock back to the issuer. After these transactions, he directly owned 47,811 shares of Calumet, Inc. common stock. This pattern reflects routine equity compensation vesting, with part of the award used to satisfy taxes rather than an open-market sale.
Calumet, Inc. director Stephen P. Mawer exercised 27,806 Restricted Stock Units into an equal number of common shares on March 9, 2026. All RSUs had fully vested on February 21, 2026. To cover tax withholding obligations, he surrendered 12,589 common shares back to the company. After these compensation-related transactions, he directly holds 303,310 shares of Calumet common stock.
Calumet, Inc. EVP Bruce A. Fleming exercised 20,621 Restricted Stock Units on March 9, 2026, receiving the same number of shares of common stock at a stated price of $0.00 per share. Each unit was economically equivalent to one share of common stock, and the units had vested 100% on February 21, 2026.
To cover tax withholding obligations upon delivery of the stock, Fleming surrendered 8,156 shares, a disposition treated as payment of tax liabilities rather than an open-market sale. After these transactions, he held 549,963 shares of Calumet common stock directly, reflecting a net increase in his equity position.
Calumet, Inc. chief executive officer Louis Todd Borgmann exercised 49,974 Restricted Stock Units into common stock on March 9, 2026. Each Restricted Stock Unit was the economic equivalent of one share of Calumet common stock, and 100% of these units had vested on February 21, 2026.
To cover tax withholding obligations related to this delivery, he surrendered 21,798 shares of Calumet common stock back to the company, rather than selling them on the open market. After these transactions, Borgmann directly held 263,742 shares of Calumet common stock.
Calumet, Inc. director Raymond Paul C reported awards of restricted stock units that are economically equivalent to common shares. On February 24, 2026, he acquired 854 Restricted Stock Units that are 100% vested and will be settled upon the earlier of a specified date or his termination date. He also acquired 284 Restricted Stock Units that will be settled under a Deferred Compensation Plan, with 25% vesting each July 1 beginning on July 1, 2027.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss reported receiving two grants of restricted stock units that are each economically equivalent to one share of common stock. One grant covers 256 units that are already 100% vested and will be settled on either a specified date or his termination date. A second grant covers 85 units under a deferred compensation plan, with 25% of these units scheduled to vest on July 1 of each year beginning on July 1, 2027, and settling on the earlier of a specified date or his termination date.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer received grants of restricted stock units that are the economic equivalent of common shares. One award covers 1,175 restricted stock units that are 100% vested and will be settled upon the earlier of a date he specifies or his termination date. A separate award covers 391 restricted stock units under a deferred compensation plan, which will be settled on the earlier of a specified date or his termination, with 25% of these units vesting each July 1 beginning in 2027.
Calumet, Inc. director Amy M. Schumacher reported the grant of two sets of restricted stock units tied to the company’s common stock. She acquired 782 Restricted Stock Units that are already 100% vested and will be settled upon the earlier of a date she specifies or her termination. She also received 260 Restricted Stock Units under a deferred compensation plan, with 25% scheduled to vest on July 1 of each year beginning in 2027, and these units will be settled on the earlier of a specified date or her termination.
Calumet, Inc. director Daniel J. Sajkowski reported an exercise of 5,053 Restricted Stock Units into an equal number of shares of common stock on December 4, 2025, followed by a sale of 2,022 shares of common stock the same day. The filing notes that each RSU is the economic equivalent of one Calumet common share and may be settled in stock or cash, and that the reporting person elected to have a portion of vested RSUs settled in cash. After these transactions, Sajkowski holds 85,268 shares of Calumet common stock directly.
Calumet, Inc. director Daniel J. Sajkowski reported equity award activity and a small share sale. On June 24, 2025, he exercised 3,796 Restricted Stock Units, converting them into 3,796 shares of common stock at a price of $0.00 per share.
Footnotes state each Restricted Stock Unit is economically equivalent to one common share and is 100% vested, and that he elected to receive 40% of the vested units in cash rather than stock. On the same date, he sold 1,518 common shares, leaving a direct holding of 84,237 common shares after the transactions.
Calumet, Inc. director Daniel J. Sajkowski reported a series of open-market sales of common stock under a pre-arranged Rule 10b5-1 trading plan. Between March 3 and July 1, 2025, he sold a total of 82,000 shares of common stock in five transactions at reported weighted average prices ranging from $10.66 to $15.77 per share. After the most recent sale of 2,000 shares at $15.77 per share, his direct holdings stood at 82,237 shares of Calumet, Inc. common stock.
Krutz John Robert reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. /DE reported that Chief Accounting Officer John Robert Krutz received a grant of 2,365 Restricted Stock Units on February 24, 2026. Each unit is the economic equivalent of one share of Calumet, Inc. common stock, and these units vest on February 24, 2029. After this award, Krutz holds 2,365 Restricted Stock Units directly.